Boston Trust Walden Corp Sells 121,561 Shares of STERIS plc (NYSE:STE)

Boston Trust Walden Corp lowered its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 73.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,580 shares of the medical equipment provider's stock after selling 121,561 shares during the period. Boston Trust Walden Corp's holdings in STERIS were worth $9,801,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. 1832 Asset Management L.P. bought a new stake in shares of STERIS in the 1st quarter worth about $25,000. Millburn Ridgefield Corp bought a new stake in STERIS during the 3rd quarter worth about $25,000. Catalyst Capital Advisors LLC bought a new stake in STERIS during the 3rd quarter worth about $25,000. West Tower Group LLC bought a new stake in STERIS during the 2nd quarter worth about $32,000. Finally, Global Wealth Management Investment Advisory Inc. bought a new stake in STERIS during the 3rd quarter worth about $49,000. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Stephens reissued an "overweight" rating and set a $250.00 price objective on shares of STERIS in a report on Friday, February 9th. JMP Securities restated a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, February 8th. TheStreet upgraded shares of STERIS from a "c+" rating to a "b" rating in a research report on Wednesday, February 7th. Finally, KeyCorp started coverage on shares of STERIS in a research report on Tuesday, February 6th. They set an "overweight" rating and a $253.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $239.60.

STERIS Trading Up 0.0 %

STERIS stock traded up $0.08 during trading hours on Friday, reaching $213.48. 434,361 shares of the company's stock traded hands, compared to its average volume of 414,516. The firm has a market capitalization of $21.09 billion, a price-to-earnings ratio of 37.39 and a beta of 0.79. The firm's 50 day moving average is $227.08 and its 200-day moving average is $218.63. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.49 and a current ratio of 2.43. STERIS plc has a fifty-two week low of $180.54 and a fifty-two week high of $254.00.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, beating analysts' consensus estimates of $2.17 by $0.05. The business had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. STERIS's revenue for the quarter was up 14.8% on a year-over-year basis. During the same period last year, the company posted $2.02 EPS. On average, analysts predict that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Friday, February 23rd were given a $0.52 dividend. The ex-dividend date was Thursday, February 22nd. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.97%. STERIS's dividend payout ratio is 36.43%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.